New Neuro-Oncology Research Center Opens in Indianapolis
The center aims to provide patients with brain cancer greater access to experimental clinical trials.
Updated on Oct. 22, 2026 in Cancer
Live Poll
Do you believe private funding for local research centers helps improve access to new medical treatments?
The Jeff Schwarz Center for Neuro-Oncology Research opened in Indianapolis to accelerate brain cancer treatment development. The facility aims to expand access to experimental therapies for patients facing diagnoses like glioblastoma.
Why it matters
Brain cancer diagnoses remain difficult to treat, with a current five-year relative survival rate of approximately 33%. This new facility seeks to bridge the gap between laboratory discovery and patient-facing clinical trials.
The center is supported by a $15 million total investment, including a $10 million family gift and $5 million from the medical school, to address a disease impacting an estimated 25,000 people in 2026. Precise timelines for recruitment and specific clinical trial launches remain under development.
The players
Jeff Schwarz Center for Neuro-Oncology Research
A new Indianapolis-based facility focused on accelerating brain cancer clinical trials and laboratory research.
IU School of Medicine
The institution housing the research center and contributing $5 million in funding for neuro-oncology initiatives.
The details
Operating within 12,000 square feet of the Medical Education and Research Building, the center integrates experts across neuro-oncology, imaging, data science, and immunology. By fostering collaboration between these disciplines, the facility aims to accelerate the translation of bench-top research into viable experimental treatments. This multidisciplinary approach is designed to fast-track findings from the lab directly into clinical settings.
Timeline
2019: The Schwarz family joined the university development board.
Late 2022: Jeff Schwarz received a glioblastoma diagnosis.
November 2023: Jeff Schwarz died from glioblastoma.
September 24, 2026: The university formally announced the center's creation.
Health Landscape
This facility represents a targeted expansion of the IU School of Medicine's neuro-oncology research pipeline. It signals a shift toward more integrated, multidisciplinary research hubs intended to speed the transition of discoveries from the bench to the bedside.
If you or a loved one are managing a brain cancer diagnosis, talk to your physician about the current landscape of experimental trials. This new center is intended to expand local access to novel therapies, which is a discussion worth having with your oncology team.
The takeaway
Brain cancer research is increasingly focusing on integrated, cross-disciplinary approaches to improve outcomes. Patients and families should maintain open communication with specialists to stay informed about local experimental options as new research facilities become operational.
Further reading
Learn more about local efforts and advancements in Cancer care in Indianapolis.
Source note: This article includes information reported by COLUMN: 'I Love Boosters' features wacky surrealist visuals and hilarious comedy - Indiana Daily Student.
Live Poll
Do you believe private funding for local research centers helps improve access to new medical treatments?
